SELLAS Life Sciences Group Inc. appointed Jane Wasman as chairman of the board.
Wasman is president of international, general counsel and corporate secretary at Acorda Therapeutics Inc., an Ardsley, N.Y.-based developer of neurological therapies.
New York's Sellas Life Sciences develops novel cancer immunotherapies.
